The Vanguard Group Discloses Position in Mural Oncology PLC

The Vanguard Group, Inc. has submitted a Position Disclosure under the Irish Takeover Panel Act, 1997. The disclosure pertains to Mural Oncology plc, specifying Vanguard's interests in the securities of Mural Oncology. As of June 5, 2025, Vanguard controls 772,867 units of $0.01 ordinary shares, representing 4.48% of the company's shares.

The disclosure indicates there are no interests in cash or stock-settled derivatives and no agreements to purchase or sell relevant securities beyond the stated holdings. A minor transaction was noted on $0.01 ordinary shares with the sale of 16 units at $2.57 each. There are no relevant indemnity or option arrangements related to the holdings.

No Supplemental Form 8 is attached, indicating the straightforward nature of the disclosure. This transparency is part of complying with Rule 8.3 of the 2022 takeover rules by the Irish Takeover Panel.